Ongoing Studies:

• Evaluation of the safety and efficacy of the ulthera® system for the treatment of axillary hyperhidrosis.


• A randomized, double-blind, parallel-group, multicenter, placebo-controlled study of the safety and efficacy of HTU-520 in the treatment of mild to moderate distal subungual onychomyocosis of the toenail.
  
  
• randomized double-blind, vehicle-controlled pilot study to assess the efficacy of 2.5% Benzoyl Peroxide formulated in a novel delivery system in the treatment of moderate to severe acne vulgaris


• Analysis of Phototoxicity and cosmetic efficacy of Photodynamic Skin Rejuvenation utilizing an OTC strength photodynamic agent with variable incubation periods in subjects with varying degrees of photo damage

Completed Clinical Trials:

• A split face, double-blind, randomized clinical trial of the effects of RV3718A using two applications per day to the half face for 3 months followed by 2 applications per day to the whole face for 3 months.


• The P.U.M.P Study: Patients using MICRO properly; an open-label, community based, phase IV study to assess facial acne improvement with the use of Retin-A Micro (Tretinoin gel) microsphere, 0.04% or 0.1% in a pump dispenser


• A Phase III, randomized, placebo-controlled, multi-center, double-blind study of the safety and duration of efficacy of Reloxin (Botulinum Type A Toxin) in correction of moderate to severe glabellar lines (and including a sub-study to detect any treatment-related QT interval changes)


• A multi-center, Phase 3, randomized, double-blind, clinical trial to compare the safety and efficacy Clin-RA Gel vs. Clindamycin Phosphate 1.2% Gel in the treatment of acne vulgaris


• Protocol C-05-16 Treatment of the upper arms using the ThermaCool System


• To demonstrate the ability of Onion extract cream (Mederma Cream plus SPF) to improve the cosmetic appearance of post laser scar removal


• Open-label, randomized, split-face study to evaluate the efficacy, safety and subject satisfaction of pain management during and after Restylane dermal filler injections for the correction of nasolabial folds


• A phase ¾ multi-center, open-label extension study to assess the long-term safety of repeat administrations of Reloxin in the treatment of glabellar lines


• A prospective, randomized, double-blind, placebo controlled, multicenter trial to investigate the efficacy and safety of NT 201, free of complexing proteins, in the treatment of glabellar frown lines

back to top